China is one of the countries with the highest incidence of gastric cancer. There are differences in epidemiological characteristics, clinicopathological features, tumor biological characteristics, ...treatment patterns, and drug selection between gastric cancer patients from the Eastern and Western countries. Non‐Chinese guidelines cannot specifically reflect the diagnosis and treatment characteristics for the Chinese gastric cancer patients. The Chinese Society of Clinical Oncology (CSCO) arranged for a panel of senior experts specializing in all sub‐specialties of gastric cancer to compile, discuss, and revise the guidelines on the diagnosis and treatment of gastric cancer based on the findings of evidence‐based medicine in China and abroad. By referring to the opinions of industry experts, taking into account of regional differences, giving full consideration to the accessibility of diagnosis and treatment resources, these experts have conducted experts’ consensus judgement on relevant evidence and made various grades of recommendations for the clinical diagnosis and treatment of gastric cancer to reflect the value of cancer treatment and meeting health economic indexes. This guideline uses tables and is complemented by explanatory and descriptive notes covering the diagnosis, comprehensive treatment, and follow‐up visits for gastric cancer.
DNA topoisomerases are essential to modulate DNA topology during various cellular genetic processes. The expression and distinct prognostic value of topoisomerase isoforms in non-small-cell lung ...cancer (NSCLC) is not well established. In the current study, we have examined the mRNA expression of topoisomerase isoforms by using Oncomine analysis and investigated their prognostic value via the Kaplan-Meier plotter database in NSCLC patients. Our analysis indicated that the expression level of topoisomerases in lung cancer was higher compared with normal tissues. Especially, high expression of two topoisomerase isoforms, TOP2A and TOP3A, was found to be correlated to worse overall survival (OS) in all NSCLC and lung adenocarcinoma (Ade) patients, but not in lung squamous cell carcinoma (SCC) patients. In a contrast, high expression of isoforms TOP1 and TOP2B indicated better OS in all NSCLC and Ade, but not in SCC patients. Meanwhile, high expression of TOP1MT and TOP3B was not correlated with OS in NSCLC patients. Furthermore, we also demonstrated a relationship between topoisomerase isoforms and the clinicopathological features for the NSCLC patients, such as grades, clinical stages, lymph node status, smoking status, gender, chemotherapy and radiotherapy. These results support that TOP2A and TOP3A are associated with worse prognosis in NSCLC patients. In addition, our study also shows that TOP1 and TOP2B contribute to favorable prognosis in NSCLC patients. The exact prognostic significance of TOP1MT and TOP3B need to be further elucidated. Comprehensive evaluation of expression and prognosis of topoisomerase isoforms will be a benefit for the better understanding of heterogeneity and complexity in the molecular biology of NSCLC, paving a way for more accurate prediction of prognosis and discovery of potential drug targets for NSCLC patients.
Primary familial brain calcification (PFBC) is a genetically heterogeneous disorder characterized by bilateral calcifications in the basal ganglia and other brain regions. The genetic basis of this ...disorder remains unknown in a significant portion of familial cases. Here, we reported a recessive causal gene, MYORG, for PFBC. Compound heterozygous or homozygous mutations of MYORG co-segregated completely with PFBC in six families, with logarithm of odds (LOD) score of 4.91 at the zero recombination fraction. In mice, Myorg mRNA was expressed specifically in S100β-positive astrocytes, and knockout of Myorg induced the formation of brain calcification at 9 months of age. Our findings provide strong evidence that loss-of-function mutations of MYORG cause brain calcification in humans and mice.
•MYORG is a major causal gene for autosomal recessive PFBC•Specific expression of MYORG suggests astrocyte involves in PFBC•Myorg knockout mice develops calcium deposits in the brain
Yao et al. provide evidence that MYORG is a major causal gene for autosomal recessive PFBC by a comprehensive strategy combining whole-exome sequencing analysis, Sanger sequencing, linkage analysis, RNA expression analysis, and a mouse model.
AIM To analyze the diagnostic value of a circular RNA(circR NA), circ-LDLRAD3, in pancreatic cancer.METHODS Expression levels of circ-LDLRAD3 were tested in both cells and clinical samples; the ...latter included 30 paired pancreatic cancer tissues and adjacent non-tumorous tissues, 31 plasma samples from patients with pancreatic cancer, and 31 plasma samples from healthy volunteers. Real-time quantitative reverse transcriptionpolymerase chain reaction(q RT-PCR) was performed to measure expression levels of circ-LDLRAD3 in cells and clinical samples; then, the relationship between clinicopathological factors of patient samples and expression of circ-LDLRAD3 in pancreatic cancer was analyzed. The diagnostic value of circ-LDLRAD3 was verified by receiver operating characteristic(ROC) curve analysis.RESULTS Circ-LDLRAD3 was up-regulated in pancreatic cancer cell lines(P < 0.01), pancreatic cancer tissues(P < 0.01), and plasma samples from patients with pancreatic cancer(P < 0.01). High expression of circLDLRAD3 was significantly associated with venous invasion, lymphatic invasion, and metastasis. The area under the ROC curve of circ-LDLRAD3 alone or combination with CA19-9 was 0.67 and 0.87, respectively, with a sensitivity and specificity of 0.5738(alone) and 0.7049(alone), and 0.8033(combination) and 0.9355(combination), respectively.CONCLUSION These data suggest that circ-LDLRAD3 may be a biomarker in the diagnosis of pancreatic cancer.
Display omitted
•A focus on the recent developments of supramolecular catalysis based on HCCs.•Metalloligand and self-sorting approaches are commonly used to construct HCCs.•Instances of catalytic ...macrocyclic or cage-like HCCs are discussed in detail.
The rational design and facile construction of discrete heterometallic supramolecular catalysts have precipitated a surge of research interest in emulating sophisticated natural catalysts with well-defined cavities and inlaid active sites, allowing conversion of encapsulated substrates with high chemo-, regio-, and stereoselectivity. This review briefly highlights such discrete, heterometallic, coordination-driven metallacycles and metallacages obtained by the strategic utilization of a range of predesigned building blocks in the supramolecular chemist’s toolkit. The two major synthetic strategies toward these metalla-architectures are presented, and special attention has been paid to discussing both the fascinating structures and the unique catalytic performance of various heterometallic macrocycles and cages.
Tremendous efforts are devoted to developing advanced electrode materials with superior electrochemical performance, high energy density, and high power density for energy storage and conversion. ...Two‐dimensional (2D) materials, owing to their unique properties, have shown great potential for energy storage. Following the discovery of graphene, a new family of 2D transition metal carbides/nitrides, MXenes, derived from MAX phase precursors, have attracted extensive attention in recent years. The superior physical and chemical properties of MXenes include high mechanical strength, excellent electrical conductivity, multiple possible surface terminations, hydrophilic features, superior specific surface area, and the ability to accommodate intercalants. When applied as electrodes in lithium‐based batteries, MXenes have demonstrated excellent performance. In this progress report, the authors summarize the recent advances of MXenes and MXene‐based composites in terms of synthesis strategies, morphology engineering, physical/chemical properties, and their applications in lithium‐ion batteries and lithium–sulfur batteries. Furthermore, challenges and perspectives for MXenes and MXene‐based composites for lithium‐based energy storage devices are also outlined.
MXenes, as a new family of two‐dimensional transition metal carbides and nitrides, have exhibited great potential as advanced electrode materials for lithium‐based batteries. This report summarizes the recent advances of MXenes in terms of synthesis strategies, morphology engineering, physical and chemical properties, and development of lithium‐based batteries.
A dual-emission ratio-fluorescent sensing nanohybrid based on Radix Hedysari green-synthesized carbon quantum dots (CDs) and glutathione-functionalized gold nanoclusters (GSH-AuNCs) had been ...developed for the determination of cefodizime sodium (CDZM). The designed fluorescence nanohybrid had two significant fluorescence emission peaks at 458 nm and 569 nm when excited at 360 nm, which was attributed to the CDs and GSH-AuNCs. With the addition of CDZM, the fluorescence at 458 nm was slightly weakened while the fluorescence at 569 nm was enhanced obviously. Based on the relationship between the I569/I458 fluorescence intensity ratio and the concentration of CDZM, the designed nanohybrid exhibited a good linearity range of 1.0–1000.0 μM and the limit of detection (LOD) was 0.19 μM. The method was finally applied in the detection of CDZM in urine, showing the potential applications in complicated biological samples.
As a key element of the silicon growth furnace, the heating power supply plays an important role to form the required thermal field for mono‐silicon growth. The performance of the heating power ...supply system is critical to implement the function, which is determined by both hardware topology and control strategies. In this paper, a novel two‐stages soft‐switching power supply topology is employed to improve the efficiency of the power supply system. Meanwhile, the robust control methods are proposed for both stages converter to achieve high power factor (PF), low total harmonic distortion (THD) and stable output DC voltage under parameters uncertainty or load perturbation. The simulation and experiment results show the correctness of analysis and the effectiveness of the proposed methods. The robust control strategies combined with the advanced soft switching topology improve the system performance for the practical applications.
A doubly heavy baryon can be regarded as composed of a heavy diquark and a light quark. In this picture, we study the masses of the doubly heavy diquarks in the Bethe-Salpeter (BS) formalism first, ...which are then used as one of the inputs in studying the masses of the doubly heavy baryons in the quark-diquark model. We establish the BS equations for both the heavy diquarks and the heavy baryons with and without taking the heavy quark limit, respectively. These equations are solved numerically with the kernel containing the scalar confinement and one-gluon-exchange terms. The mass of the doubly charmed baryon Ξcc(⁎) is obtained in both approaches, 3.60∼3.65GeV (Ξcc(⁎)) under the heavy quark limit, 3.53∼3.56GeV for Ξcc and 3.61∼3.63GeV for Ξcc⁎ without taking the heavy quark limit. The masses of Ξbc′, Ξbc(⁎), Ξbb(⁎), Ωcc(⁎), Ωbc′, Ωbc(⁎) and Ωbb(⁎) are also predicted in the same way. We find that the corrections to the results in the heavy quark limit are about −0.02GeV∼−0.11GeV for the masses of the doubly heavy baryons.
Post-traumatic osteoarthritis (PTOA) develops after joint injury. Specifically, patients with anterior cruciate ligament (ACL) injury have a high risk of developing PTOA. In this review, we outline ...the incidence of ACL injury that progresses to PTOA, analyze the role of ACL reconstruction in preventing PTOA, suggest possible mechanisms thought to be responsible for PTOA, evaluate current diagnostic methods for detecting early OA, and discuss potential interventions to combat PTOA. We also identify important directions for future research. Although much work has been done, the incidence of PTOA among patients with a history of ACL injury remains high due to the complexity of ACL injury progression to PTOA, the lack of sensitive and easily accessible diagnostic methods to detect OA development, and the limitations of current treatments. A number of factors are thought to be involved in the underlying mechanism, including structural factors, biological factors, mechanical factors, and neuromuscular factor. Since there is a clear "start point" for PTOA, early detection and intervention is of great importance. Currently, imaging modalities and specific biomarkers allow early detection of PTOA. However, none of them is both sensitive and easily accessible. After ACL injury, many patients undergo surgical reconstruction of ACL to restore joint stability and prevent excessive loading. However, convincing evidence is still lacking for the superiority of ACL-R to conservative management in term of the incidence of PTOA. As for non-surgical treatment such as anti-cytokine and chemokine interventions, most of them are investigated in animal studies and have not been applied to humans. A complete understanding of mechanisms to stratify the patients into different subgroups on the basis of risk factors is critical. And the improvement of standardized and quantitative assessment techniques is necessary to guide intervention. Moreover, treatments targeted toward different pathogenic pathways may be crucial to the management of PTOA in the future.
PDF
